Getein Biotech, Inc / Fundamentals
Income statement
- Net revenue
€128.27M - Cost of goods sold
€39.41M - Gross profit
€88.86M - SG&A expenses
€18.02M - R&D expenses
€20.85M - EBITDA
€25.54M - D&A
-€3.25M - EBIT
€28.03M - Interest expenses
€1.61M - EBT
€27.21M - Tax expenses
€1.94M - Net income
€25.72M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€17.64M - Changes in working capital
€0.00 - Operating cash flow
€24.35M - Capex
€24.12M - Other investing cash flow
-€10.91M - Net investing cash flow
-€48.61M - Total cash dividends paid
-€12.65M - Issuance of common stock
€0.00 - Debt repayment
€6.40M - Other financing cash flow
-€2.10M - Net financing cash flow
-€8.36M - Foreign exchange effects
€444.88K - Net change in cash
-€5.31M - Cash at end of period
€48.13M - Free cash flow
€48.47M
Balance sheet
- Cash and cash equivalents
€48.24M - Cash and short-term investments
€139.17M - Total receivables
€53.82M - Inventory
€21.65M - Other current assets
€66.32M - Total current assets
€280.96M - Property, plant & equipment
€88.93M - Goodwill
€1.45M - Intangible assets
€24.60M - Long-term investments
€0.00 - Other non-current assets
€70.95M - Total non-current assets
€192.28M - Total assets
€473.23M - Accounts payable
€27.91M - Short-term debt
€82.80M - Other current liabilities
€15.82M - Total current liabilities
€128.74M - Long-term debt
€211.64K - Deferred tax liabilities
€3.51M - Other non-current liabilities
€0.00 - Total non-current liabilities
€5.78M - Total liabilities
€134.52M - Common stock
€61.38M - Retained earnings
€203.67M - Other equity
€0.00 - Total equity
€338.71M - Total liabilities and shareholders' equity
€473.23M
Company information
- Market capitalization
€479.72M - Employees
1.9K - Enterprise Value
€4.54B
Company ratios
- Gross margin
-
69.3% Much better than peer group: 48.2% - EBITDA margin
-
19.9% Worse than peer group: 29.9% - EBIT margin
-
21.9% Even with peer group: 25.1% - EBT margin
-
21.2% Even with peer group: 25.7% - Net margin
-
20.1% Even with peer group: 20.8% - ROE
-
7.6% Worse than peer group: 19.2% - ROA
-
5.4% Worse than peer group: 14.4% - Asset turnover
-
27.1% Much worse than peer group: 75.3% - FCF margin
-
0.2% Worse than peer group: 9.1% - FCF yield
0.0% - Efficiency ratio
80.1% - Net sales per employee
-
€65.88K - Net income per employee
-
€13.21K